Related Experiment Video
Updated: Jan 29, 2026

08:51
Quantification of Coenzyme A in Cells and Tissues
Published on: September 27, 2019
8.9K
Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview
David Mantle1, Iain Hargreaves2
1Pharma Nord (UK) Ltd., Telford Court, Morpeth, NE61 2DB Northumberland, UK. dmantle@pharmanord.co.uk.
Antioxidants (Basel, Switzerland)
|February 21, 2019
Summary
Coenzyme Q10 (CoQ10) supplementation shows significant potential in promoting longevity by reducing mortality and managing degenerative diseases like cardiovascular, diabetes, kidney, and liver conditions.
Area of Science:
- Biochemistry
- Gerontology
- Nutritional Science
Background:
- Longevity is influenced by genetic, environmental, and lifestyle factors.
- Degenerative disorders (cardiovascular, diabetes, kidney, liver disease) significantly impact lifespan, especially when co-morbid.
- Coenzyme Q10 (CoQ10) is a vital compound in cellular energy production and possesses antioxidant properties.
Purpose of the Study:
- To review the potential role of Coenzyme Q10 (CoQ10) supplementation in preventing or managing major degenerative disorders.
- To explore CoQ10's impact on longevity and age-related diseases.
Main Methods:
- Review of randomized controlled clinical trials.
- Analysis of studies investigating CoQ10 supplementation in cardiovascular disease, type II diabetes, chronic kidney disease, and non-alcoholic fatty liver disease.
Main Results:
- CoQ10 supplementation reduced mortality by approximately 50% in cardiovascular disease patients and the elderly population.
- CoQ10 improved glycemic control and vascular function in type II diabetes.
- CoQ10 enhanced renal function in chronic kidney disease and reduced liver inflammation in non-alcoholic fatty liver disease.
Conclusions:
- Coenzyme Q10 (CoQ10) supplementation demonstrates a significant beneficial role in managing major degenerative disorders.
- CoQ10's positive effects are attributed to its functions in cellular energy generation, antioxidant activity, and anti-inflammatory properties.
- CoQ10 supplementation may be a valuable strategy for promoting longevity and improving health outcomes in aging populations.
Related Concept Videos
Cofactors and Coenzymes
87.3K
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
87.3K
Cofactors and Coenzymes
12.8K
Enzymes are proteins made of amino acids. The functional group of each constituent amino acid catalyzes a wide variety of chemical reactions via ionic interactions or acid-base reactions. However, amino acids cannot catalyze oxidation-reduction and group transfer reactions and need to be aided by non-protein components called cofactors. Cofactors are also referred to as the chemical teeth of an enzyme.
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
12.8K
Drugs Used in Lower Respiratory Disorders: Overview
1.1K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.1K
Drugs Used in Upper Respiratory Disorders: Overview
654
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
654
Intrinsically Disordered Proteins
19.4K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.4K
Role of Reduced Coenzymes NADH and FADH₂
16.5K
The energy released from the breakdown of the chemical bonds within nutrients can be stored either through the reduction of electron carriers or in the bonds of adenosine triphosphate (ATP). In living systems, a small class of compounds functions as mobile electron carriers, molecules that bind to and shuttle high-energy electrons between compounds in pathways. The principal electron carriers that will be considered originate from the B vitamin group and are derivatives of nucleotides; they are...
16.5K

